Old Web
Therapeutics: Selective inhibitors gain traction
2010
A selective TORC1 and TORC2 active site inhibitor has high efficacy and tolerability in models of acute leukaemia.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
0
Citations
NaN
KQI